Credence Research Logo

Home » Healthcare » Pharmaceuticals » Marknad för självadministrerade läkemedel

Marknad för självadministrerade läkemedel efter läkemedelstyp (injektionsläkemedel, orala läkemedel, inhalerbara läkemedel, transdermala läkemedel); efter terapeutiskt område (diabetes, hjärt-kärlsjukdomar, andningssjukdomar, andra); efter distributionskanal (sjukhusapotek, detaljhandelsapotek, onlineapotek); efter doseringsform (tabletter och kapslar, injektioner, sprayer och inhalatorer, plåster och geler); efter geografi – tillväxt, andel, möjligheter och konkurrensanalys, 2024 – 2032

Report ID: 201681 | Report Format : Excel, PDF

Begär ett gratisprov

Begär gratis prov

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Begär din provrapport och börja din resa mot välgrundade beslut

Tillhandahåller den strategiska kompassen för branschledare.

cr-clients-logos
Vanliga frågor
Vad är den nuvarande marknadsstorleken för marknaden för självadministrerade läkemedel, och vad är dess förväntade storlek år 2032?

Marknaden för självadministrerade läkemedel värderades till 22,7 miljarder USD år 2024 och förväntas nå 28,84 miljarder USD år 2032.

Vilken årlig sammansatt tillväxttakt förväntas marknaden för självadministrerade läkemedel växa med mellan 2025 och 2032?

Marknaden för självadministrerade läkemedel förväntas växa med en CAGR på 3,04% under prognosperioden.

Vilken marknadssegment för självadministrerade läkemedel hade den största andelen 2024?

Segmentet för injicerbara läkemedel hade den största andelen på 47,2 % år 2024, stödd av den växande användningen av autoinjektorer och bärbara leveranssystem.

Vilka är de främsta faktorerna som driver tillväxten av marknaden för självadministrerade läkemedel?

Nyckelfaktorer inkluderar ökande prevalens av kroniska sjukdomar, teknologiska framsteg inom läkemedelsleverans och den globala övergången till hemvård.

Vilka är de ledande företagen på marknaden för självadministrerade läkemedel?

Stora aktörer inkluderar Pfizer Inc., Novartis AG, Amgen Inc., AstraZeneca plc, Johnson & Johnson och Eli Lilly and Company.

Vilken region hade den största andelen av marknaden för självadministrerade läkemedel år 2024?

Nordamerika ledde marknaden för självadministrerade läkemedel med en andel på 39,6 % år 2024, drivet av en stark hälsoinfrastruktur och avancerad användning av självadministrationsteknologier.

About Author

Shweta Bisht

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports

North America Immunology Drugs Market

The North America Immunology Drugs Market size was valued at USD 23,174.02 MN in 2021 and reached USD 34,194.85 MN in 2025. It is anticipated to reach USD 70,564.69 MN by 2032, growing at a CAGR of 9.11% during the forecast period.

Europe Anticancer Drugs/Oncology Drugs Market

The Europe Anticancer Drugs/Oncology Drugs Market size was valued at USD 52,704.85 MN in 2021 and reached USD 71,835.97 MN in 2025. It is anticipated to reach USD 125,841.34 MN by 2032, growing at a CAGR of 8.34% during the forecast period.

North America Antidiabetics Drug Market

The North America Antidiabetics Drug Market size was valued at USD 18,811.60 MN in 2021 and reached USD 25,029.65 MN in 2025. It is anticipated to reach USD 42,563.34 MN by 2032, growing at a CAGR of 6.60% during the forecast period.

Dipeptide Peptidase 4 (DPP-4) Inhibitors Market

The Dipeptide Peptidase 4 (DPP-4) Inhibitors Market size was estimated at USD 11,280.60 million in 2025 and is expected to reach USD 15,527.66 million by 2032, growing at a CAGR of 5.47% from 2025 to 2032.

Diphenhydramine Market

The Diphenhydramine Market size was estimated at USD 1,680.45 million in 2025 and is expected to reach USD 2,204.77 million by 2032, growing at a CAGR of 4.63% from 2025 to 2032.

Intraosseous Devices Market

The Intraosseous Devices Market size was valued at USD 448 million in 2024 and is anticipated to reach USD 612.55 million by 2032, growing at a CAGR of 3.98% during the forecast period.

Dilated Cardiomyopathy Therapeutics Market

The Dilated Cardiomyopathy Therapeutic Market size was estimated at USD 5,240.95 million in 2025 and is expected to reach USD 8,025.37 million by 2032, growing at a CAGR of 7.36% from 2025 to 2032.

Divalproex Sodium Market

The Divalproex Sodium Market size was estimated at USD 1,860.58 million in 2025 and is expected to reach USD 2,453.73 million by 2032, growing at a CAGR of 4.72% from 2025 to 2032.

Somatostatin Analogs Market

The global somatostatin analogs market was valued at USD 7,187.5 million in 2024 and is projected to reach USD 12,349.46 million by 2032, expanding at a compound annual growth rate (CAGR) of 7% during the forecast period.

Respiratory Disease Vaccine Market

The global respiratory disease vaccine market was valued at USD 94,579.5 million in 2024 and is projected to reach USD 102,011.14 million by 2032, expanding at a compound annual growth rate (CAGR) of 2.1% during the forecast period

Respiratory Syncytial Virus Therapeutics Market

The Respiratory Syncytial Virus (RSV) Therapeutics market was valued at USD 1,542.48 million in 2024 and is projected to reach USD 4,493.54 million by 2032, expanding at a strong CAGR of 14.3% during the forecast period.

Vitamin K Market

Vitamin K market size was valued USD 2,448.6 Million in 2024 and is anticipated to reach USD 3,645.35 Million by 2032, at a CAGR of 5.1% during the forecast period.

Licensalternativ

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
$7999

Report delivery within 24 to 48 hours

Snabbkontakt

Europe

+44 7453 598 606

North America

+1 6282 627 656

Email

[email protected]

Begär ett gratisprov

Smallform of Sample request

What people say?

User Review

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materialforskare
(privacy requested)

User Review

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Ledningsassistent, Bekaert

Betrodd av

cr-clients-logos

Request Sample